首页> 美国卫生研究院文献>OncoTargets and therapy >Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma

【2h】

Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma

机译：尼妥珠单抗联合同期放化疗对晚期鼻咽癌患者有益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe potential benefits and possible risks associated with combined nimotuzumab and concurrent chemoradiotherapy in patients with advanced nasopharyngeal carcinoma (NPC) have yet to be determined.

机译：背景：尼妥珠单抗联合同时放化疗对晚期鼻咽癌（NPC）患者的潜在益处和潜在风险尚未确定。

著录项

期刊名称 OncoTargets and therapy
作者
Zhanzhan Li; Yanyan Li; Shipeng Yan; Jun Fu; Qin Zhou; Xinqiong Huang; Liangfang Shen;
展开▼
作者单位

展开▼
年(卷),期 2017(10),-1
年度 2017
页码 5445–5458
总页数 14
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
randomized controlled trial cohort studies nasopharyngeal carcinoma relative risk radiotherapy chemoradiotherapy;

机译：随机对照试验;队列研究;鼻咽癌;相对危险度;放疗;放化疗;

相似文献

外文文献
中文文献
专利

1. Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma [J] . Zhanzhan Li, Yanyan Li, Shipeng Yan, OncoTargets and therapy . 2017,第4期

机译：尼妥珠单抗联合同期放化疗对晚期鼻咽癌患者有益
2. Comparing treatment outcomes of concurrent chemoradiotherapy with or without nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma [J] . Yao Ji-Jin, Zhang Lu-Lu, Gao Tian-Sheng, Cancer biology & therapy . 2018,第10a12期

机译：在型鼻咽癌患者患者中比较随尼古拉姆的并发化学疗法的治疗结果
3. Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter randomized controlled study [J] . Ying Lu, Dagui Chen, Jinhui Liang, BMC Cancer . 2019,第1期

机译：Nimotuzumab的施用结合顺铂加5-氟尿嘧啶作为诱导治疗，改善局部晚期鼻咽癌患者的治疗响应和耐受性，接受并发放射化学疗法：多中心随机对照研究
4. Efficacy of Intraperitoneal Perfusion Hyperthermic Chemotheraphy(CHIP)With Cisplatin Combined With Intraveuous Chemotherapy for Patients With Advanced Gastrointestinal Carcinoma [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：腹腔灌注热化学疗法（CHIP）联合顺铂联合静脉化疗治疗晚期胃肠道癌的疗效
5. Clinical studies of immunomodulatory activities of Yunzhi -Danshen in breast cancer and nasopharyngeal carcinoma patients, and Lingzhi-San Miao San in rheumatoid arthritis patients. [D] . Bao, Yixi. 2005

机译：云芝丹参对乳腺癌和鼻咽癌患者及类风湿关节炎灵芝三妙散的免疫调节活性的临床研究。
6. Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis [O] . Zhi-gang Liu, Yu Zhao, Jiao Tang, 2016

机译：尼妥珠单抗联合同期放化疗治疗局部晚期鼻咽癌的回顾性分析
7. Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma [O] . Zhanzhan Li, Yanyan Li, Shipeng Yan, 2017

机译：Nimotuzumab结合同时的化学疗法益处晚期鼻咽癌患者

Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅